Comorbidity and polypharmacy impact neurobehavioral symptoms and symptom validity failure among post-9/11 veterans with mild traumatic brain injury
- PMID: 37538260
- PMCID: PMC10395329
- DOI: 10.3389/fneur.2023.1228377
Comorbidity and polypharmacy impact neurobehavioral symptoms and symptom validity failure among post-9/11 veterans with mild traumatic brain injury
Abstract
Objective: The study aimed to examine the association between post-concussive comorbidity burdens [post-traumatic stress disorder (PTSD), depression, and/or headache] and central nervous system (CNS) polypharmacy (five or more concurrent medications) with reported neurobehavioral symptoms and symptom validity screening among post-9/11 veterans with a history of mild traumatic brain injury (mTBI).
Setting: Administrative medical record data from the Department of Veterans Affairs (VA) were used in the study.
Participants: Post-9/11 veterans with mTBI and at least 2 years of VA care between 2001 and 2019 who had completed the comprehensive traumatic brain injury evaluation (CTBIE) were included in the study.
Design: Retrospective cross-sectional design was used in the study.
Main measures: Neurobehavioral Symptom Inventory (NSI), International Classification of Diseases, Ninth Revision, and Clinical Modification diagnosis codes were included in the study.
Results: Of the 92,495 veterans with a history of TBI, 90% had diagnoses of at least one identified comorbidity (PTSD, depression, and/or headache) and 28% had evidence of CNS polypharmacy. Neurobehavioral symptom reporting and symptom validity failure was associated with comorbidity burden and polypharmacy after adjusting for sociodemographic characteristics. Veterans with concurrent diagnoses of PTSD, depression, and headache were more than six times more likely [Adjusted odds ratio = 6.55 (99% CI: 5.41, 7.92)]. to fail the embedded symptom validity measure (Validity-10) in the NSI.
Conclusion: TBI-related multimorbidity and CNS polypharmacy had the strongest association with neurobehavioral symptom distress, even after accounting for injury and sociodemographic characteristics. Given the regular use of the NSI in clinical and research settings, these findings emphasize the need for comprehensive neuropsychological evaluation for individuals who screen positively for potential symptom overreporting, the importance of multidisciplinary rehabilitation to restore functioning following mTBI, and the conscientious utilization of symptom validity measures in research efforts.
Keywords: concussion; headache; multimorbidity; polypharmacy; post-traumatic stress disorders; veterans.
Copyright © 2023 Swan, Kennedy, Cooper, Amuan, Mayo, Tate, Song, Eapen, Van Cott, Lopez and Pugh.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
An Examination of Racial/Ethnic Differences on the Neurobehavioral Symptom Inventory Among Veterans Completing the Comprehensive Traumatic Brain Injury Evaluation: A Veterans Affairs Million Veteran Program Study.Arch Clin Neuropsychol. 2023 Aug 24;38(6):929-943. doi: 10.1093/arclin/acad005. Arch Clin Neuropsychol. 2023. PMID: 36702773 Free PMC article.
-
Postconcussive symptoms (PCS) following combat-related traumatic brain injury (TBI) in Veterans with posttraumatic stress disorder (PTSD): Influence of TBI, PTSD, and depression on symptoms measured by the Neurobehavioral Symptom Inventory (NSI).J Psychiatr Res. 2018 Jul;102:8-13. doi: 10.1016/j.jpsychires.2018.03.004. Epub 2018 Mar 10. J Psychiatr Res. 2018. PMID: 29554536
-
Sex differences in symptom presentation and functional outcomes: a pilot study in a matched sample of veterans with mild TBI.Brain Inj. 2020 Mar 20;34(4):535-547. doi: 10.1080/02699052.2020.1725979. Epub 2020 Feb 17. Brain Inj. 2020. PMID: 32064965
-
Network Analysis of Neurobehavioral and Post-Traumatic Stress Disorder Symptoms One Year after Traumatic Brain Injury: A Veterans Affairs Traumatic Brain Injury Model Systems Study.J Neurotrauma. 2021 Dec;38(23):3332-3340. doi: 10.1089/neu.2021.0200. J Neurotrauma. 2021. PMID: 34652955
-
Evaluation of post-traumatic stress disorder (PTSD) and related comorbidities in clinical studies.J Med Life. 2022 Apr;15(4):436-442. doi: 10.25122/jml-2022-0120. J Med Life. 2022. PMID: 35646173 Free PMC article. Review.
References
-
- DOD TBI Worldwide Numbers . Military Health System. Available online at: https://armymedicine.health.mil/MHSHome/Military-Health-Topics/Centers-o... (accessed December 29, 2022).
-
- Pugh MJ, Swan AA, Amuan ME, Eapen BC, Jaramillo CA, Delgado R, et al. . Deployment, suicide, and overdose among comorbidity phenotypes following mild traumatic brain injury: a retrospective cohort study from the Chronic Effects of Neurotrauma Consortium Agarwal S, editor. PLoS ONE. (2019) 14:e0222674. 10.1371/journal.pone.0222674 - DOI - PMC - PubMed
-
- Eide RP, Stahlman S. Polypharmacy involving opioid, psychotropic, and central nervous system depressant medications, period prevalence and association with suicidal ideation, active component, U.S. Armed Forces, 2016. MSMR. (2018) 25:2–9. - PubMed
LinkOut - more resources
Full Text Sources